Having trouble viewing this in your email? Click here to see it in a browser

Logo of the WVU Cancer Institute.
Upcoming Events weeks of May 18 - May 24

For Coronavirus (COVID-19) information for WVU Students or Staff, please visit coronavirus.wvu.edu

We are keenly aware at this time for the need to balance cancer care and risk for our patients. Those patients currently under treatment will continue their treatments. You can follow the latest on coronavirus updates from WVUMedicine

Dr. Anne Swisher standing in front of the science based poster she presented at a recent conference.

WVU Cancer Institute’s Angelica Oberholtzer Jacques

Anni Jacques, seated at a table with her sewing machine and sewing supples for making masks.
The Cancer Institute has a healthcare superhero whose secret identity is about to be exposed. Anni Jacques, is the woman behind the mask – or, rather masks, as she has made around 1,750 coverings for providers and patients at the Cancer Institute and J.W. Ruby Memorial Hospital during the COVID-19 pandemic.

Jacques is supposed to be on leave. She is a technician for Christopher Cifarelli, MD, PhD, a neurosurgeon whose cancer research has been put on hold while the hospital focuses its services exclusively on patient care. “I couldn’t do my job as a technician and was stuck at home going crazy,” she said. “But then I remembered, I can sew. I have a sewing machine. I can do something useful.”

Jacques has been toiling alone in a conference room at the Cancer Institute since April 4, producing about 60 masks a day. She has been using cotton and cotton/linen blends from fabric that comes mostly from her mother in Texas. A friend is adding to the effort by making ear savers. “The stores in Texas have been open while ours have not,” she said. “I’m getting fabric, ribbons and thread from out of state.”

The masks designs are random, based on whatever fabric Jacques has on hand. She has made some with a cow pattern, Paw Patrol characters and NFL team logos. Around a third of the masks are for pediatric patients. Jacques places the masks in a laundry bin in an office on the main floor of the Cancer Institute. Some are delivered to the Department of Pediatrics, some are delivered to incident command at the hospital and the rest are available to anyone who needs one. “I’m going to make them until they tell me to stop,” Jacques said. “Or if we don’t need them, we can store the unused ones in case something like this happens again.”


WVU School of Medicine named one of the most competitive nationally by U.S. News

In a recent U.S. News report, the West Virginia University School of Medicine has been recognized for its competitive nature and standards, being named to the top 10 lowest acceptance rates in the country for the M.D. program.


Seven Faculty named to Faculty Fellows Program to develop new Honors courses

Dr. Steven Frisch, Biochemistry, School of Medicine

Portrait style head and shoulders of Dr. Steven Frisch.
“The Biology of Aging” will be a multidisciplinary examination of biologic aging and the factors that affect and can extend longevity. Students will learn about the exciting study of “cell senescence,” or the irreversible cessation of cell division. Students will explore work that shows cell senescence as the major factor underlying human aging and learn about new interventions that prevent cell senescence in model organisms, extending their longevity. What could this mean for humans and aging in the future?


From Practice To Theory: A Graduate’s Journey To Becoming An Epidemiologist


As an AmeriCorps Vista, Tressler was given the opportunity to work with the Berkeley and Jefferson County Health Departments. This led to opportunities assisting Marion County and Kanawha-Charleston Health Departments with threat preparedness planning. When Tressler was later offered a position with Bonnie’s Bus, the WVU Cancer Institute’s mobile mammography program, she accepted.

“I enjoyed my work with Bonnie’s Bus, but always had epidemiology in the back of my mind and that it was something I would like to pursue further,” Tressler said.



Arif Sarwari, MD, Chair of Medicine, and Chris Goode, MD, Chair of Emergency Medicine, co-authored an article entitled “I thought I could wait this out”: fearing coronavirus, patients are delaying hospital visits, putting health and lives at risk.

We recommend this very thoughtful piece, as it illustrates the current challenge we have as we reopen our clinics and hospitals – ensuring people understand that they should not delay critical care due to their concerns about coming to one of our hospitals or clinics. Our hospitals and clinics are safe, and we can protect our patients, especially since we’ve not experienced the same surge that places such as New York City or Los Angeles have. Here is one of the most sobering facts that they share: “The ultimate cost for delaying treatment can be loss of life. Data from the CDC shows the U.S. had 66,000 more deaths than expected from January through the end of April, with only about half of those linked to COVID-19.” Please help us deliver this message through your network of family, friends, and acquaintances.


Virtual Mindfulness Sampler Workshop Series Starting May 18

Work with three incredibly knowledgeable and experienced instructors in developing a mindfulness practice that supports your work-life balance and overall well-being.  Participants can expect to be engaged in a variety of mindful exercises purposefully designed to provide personal and professional value, including:

  • The science of mindfulness and its positive effects on the brain
  • Guided meditation for mental clarity and focus
  • Energizing yoga poses capable of being done at home or in the office with limited space or props
  • Mindful compassion, communication, and eating exercises

This weekly workshop series will cover techniques to effectively change your response to stress, the result of which is a calmer, more focused and resilient mind. The virtual series will take place every Monday at noon from May 18 to June 22 and is free for all WVU Medicine employees and WVU students, faculty, and staff. 

For additional information or to register contact wellness specialist Anthony.Danko@hsc.wvu.edu.

 

* Some of these articles may require a subscription to the newspaper or service

Advisory commission on COVID-19 race disparities holds first meeting
Tiffany Walker-Samuels, a commission member who works for the WVU Cancer Institute through the WVU Foundation, suggested access to testing without the requirement of seeing a primary care provider first could help. -State Journal Online

Recent Publications button

Formation of eruptive cutaneous squamous cell carcinomas after programmed cell death protein-1 blockade.
Marsh RL, Kolodney JA, Iyengar S, Yousaf A, Louden BA, Al-Bouri A, Kolodney MS.
JAAD Case Rep. 2020;6(5):390-393.

Eligibility criteria for patients undergoing allogeneic hematopoietic cell transplantation.
Kanate AS, Perales MA, Hamadani M.
J Natl Compr Canc Netw. 2020;18(5):635-643.

An unsupervised strategy for identifying epithelial-mesenchymal transition state metrics in breast cancer and melanoma.
Klinke DJ, 2nd, Torang A.
iScience. 2020;23(5):101080.

Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.
Patel RJ, Kejner A, McMullen C.
Head Neck. 2020.

NIH Notices
Request for Information (RFI) on Developing an Online Educational Resource for Training in the Principles of Rigorous Research
(NOT-NS-20-062)

Request for Information (RFI): Strategy for Research in Coronavirus Serology Testing and Serological Sciences

Notice of NCI's Participation on PA-20-199, "Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Not Allowed)
(NOT-CA-20-062)

Notice of NCI's Participation on PA-20-197, "Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial Required)
(NOT-CA-20-063)

Notice of NCI's Participation on PA-20-198, "Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
(NOT-CA-20-064)

Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)
(NOT-CA-20-067)

NIH Funding Opportunities

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)
(PA-20-203)

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)
(PA-20-202)

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
(PA-20-201)

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)
(PA-20-204)

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)
(PA-20-205)

Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)
(PA-20-206)

Metastasis Research Network (U54 Clinical Trial Not Allowed)
(RFA-CA-20-029)

Other Funding or Opportunities

DoD Breast Cancer, Innovator Award
Upcoming Deadline: Pre-application: June 24, 2020, Application (Invitation only): Oct. 6, 2020
The Innovator Award supports visionary individuals who have demonstrated exceptional creativity, innovative work, and paradigm-shifting leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could accelerate progress to ending breast cancer. Because the intent of the Innovator Award mechanism is to recognize these remarkably creative and innovative visionary individuals, rather than projects, the central feature of the award is the innovative contribution that the PI can make toward ending breast cancer. The PI should have a record of challenging the status quo, shifting paradigms by changing a field of research or approach to patient care, exhibiting high levels of creativity, and demonstrating promise for continued innovation in future work. The PI is also expected to be established in their field and have demonstrated success at forming and leading effective partnerships and collaborations.The CDMRP expects to fund one Innovator Award.


DoD Breast Cancer, Breakthrough Award Levels 1 and 2
Upcoming Deadline: Pre-application: Sept. 8, 2020, Application: Sept. 22, 2020
The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer.


DoD Breast Cancer, Breakthrough Award Levels 3
Upcoming Deadline: Pre-application: June 24, 2020, Application (Invitation only): Oct. 6, 2020
The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The CDMRP expects to fund one Breakthrough Award Level 3 application.


DoD Breast Cancer, Breakthrough Award Levels 4 (Clinical Trial required)
Upcoming Deadline: Pre-application: June 24, 2020, Application (Invitation only): October 6, 2020
The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The CDMRP expects to fund one Breakthrough Award Level 4 application.


DoD Breast Cancer, Era of Hope Scholar Award
Upcoming Deadline: Pre-application: Sept 8, 2020, Application: Sept. 22,, 2020
The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the "best and brightest" in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research. The central features of the award are the demonstrated ability of the individual named as the PI to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention. The CDMRP expects to fund one application.


DoD Breast Cancer, Transformative Breast Cancer Consortium Award (TBCCA)
Upcoming Deadline: Pre-application: June 24, 2020, Application (Invitation only): Oct. 6, 2020
The TBCCA is designed to support collaborations and ideas that will transform the lives of individuals with, and/or at risk for, breast cancer and will significantly accelerate progress toward ending breast cancer. This award requires a team-based approach by a consortium of exceptional researchers and advocates, whose collaborative efforts will make a transformative impact in breast cancer. The consortium should have at least four, but no more than five, teams investigating different projects under a central hypothesis. No more than two teams may be based at one institution. Each team's work must be integrated within the consortium so that every component is working toward the consortium's central hypothesis. The CDMRP expects to fund one application.


General Surgery Resident Research Initiation Grant: American Society of Colon and Rectal Surgeons (ASCRS) Research Foundation
Upcoming Deadline: Application: Aug 15, 2020
The purpose of the grant is to attract General Surgery Residents or recent Graduates of such programs into the field of Colon and Rectal Surgery by providing opportunities to engage in clinical or laboratory-based research focused on diseases of the colon, rectum and anus.


Professor Grants - Clinical Research Professor Grants: American Cancer Society (ACS)
Upcoming Deadline: Letter of Intent: Aug. 1, 2020; Application (if invited): Oct. 15, 2020
Abstract: The ACS offers a limited number of grants to investigators who have had the rank of full professor for 15 years or less and made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy, or epidemiologic cancer research.

See more on the WVU Cancer Institute Calendar